Abstract
Polymorphism in the apolipoprotein E gene has been associated with several neurological, cardiological and ophthalmological diseases. Apolipoprotein E is involved in psoriasis by modifying mitogen-activated T lymphocyte proliferation and by assuring protection against some infections. We evaluated the apolipoprotein E gene polymorphism in patients suffering from psoriasis (compared to matched controls) in Thrace, Northern Greece. One hundred and forty patients suffering from psoriasis vulgaris and 155 matched controls were included in this study and genotyped by semi-nested polymerase chain reaction RFLPs; the results were evaluated by conditional logistic regression. In psoriasis vulgaris patients, the e2 allele showed higher frequency (6.1%, P = 0.021) versus matched controls (2.3%). The above data were ascertained particularly enforced in psoriasis vulgaris male patients (P = 0.031) as well as in late onset psoriasis vulgaris (P = 0.029). Implication of apolipoprotein E in the pathogenesis of psoriasis has been indicated. Allele e2 is more frequent in psoriatic patients and its presence is more evident in late onset psoriasis vulgaris.
Similar content being viewed by others
References
Angeli V, Liodra J, Rong JX, Satoh K, Shimizu T, Fisher EA, Randolph GJ (2004) Dyslipidemia associated with atherosclerotic disease systemically alters dendritic cell mobilization. Immunity 21:561–574. doi:10.1016/j.immuni.2004.09.003
Bhalerao J, Bowcock A (1998) The genetics of psoriasis: a complex disorder of the skin and immune system. Hum Mol Genet 7(10):1537–1545. doi:10.1093/hmg/7.10.1537
Borroni B, Di Luca M, Padovani A (2007) The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology 68(8):624
Bowcock AM, Krueger JG (2005) Getting under the skin: the immunogenetics of psoriasis. Nat Rev Immunol 5:699–711. doi:10.1038/nri1689
Campalani E, Allen MH, Fainhurst D, Young HS, Mendonca CO, Burden AD, Griffiths CEM, Crook MA, Barker JNWN, Smith H (2006) ApoE gene polymorphisms are associated with psoriasis but do not determine disease response to acitretin. Br J Dermatol 154:345–352. doi:10.1111/j.1365-2133.2005.06950.x
Capon F, Helms C, Veal CD, Tillman D, Burden AD, Barker JN, Bowcock AM, Trembath RC (2004) Genetic analysis of PRORS2 markers in UK dataset supports the association between RAPTOR SNPS and familial psoriasis. J Med Genet 41:459–460. doi:10.1136/jmg.2004.018226
Capon F, Di Meglio P, Szaub J, Prescott NJ, Dunster C, Baumber L, Timms K, Gutin A, Abhevic V, Burden AD, Lanchbury J, Barker J, Trembath RC, Nestle FQ (2007) Sequence variants in the genes for the interleukin-23 receptor (IL23 K) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 122:201–206. doi:10.1007/s00439-007-0397-0
Cargill M, Schrodi SJ, Chang M, Garcia VE, Brandon K, Callis KP, Matsunami N, Ardlie KG, Civello D, Catanese JJ, Leong DU, Panko JM, McAllister LB, Hansen CB, Papenfuss J, Prescott SM, White TJ, Leppert MF, Krueger GG, Begovich AB (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80:273–290. doi:10.1086/511051
Cariolou MA, Kokkofitou A, Manoli P, Christou S, Karagrigoriou A, Middleton L (1995) Underexpression of the apolipoprotein E2 and E4 alleles in the Greek Cypriot population of Cyprous. Genet Epidemiol 12(5):489–497. doi:10.1002/gepi.1370120506
Corbo RM, Scacci R (1999) Apolipoprotein E allele distribution in the world. Is apo E4 a thrifty allele? Ann Hum Genet 63(pt 4):301–310. doi:10.1046/j.1469-1809.1999.6340301.x
Das HKJ, McPherson GA, Bruns GAP, Karathanasis SK, Breslow JL (1985) Isolation, characterization and mapping to chromosome 19 of the human apolipoprotein E gene. J Biol Chem 260:6240–6247
Duan H, Li Z, Mazzone T (1995) Tumor Necrosis Factor -a modulates monocyte/macrophage apoE gene expression. J Clin Invest 96:915–922. doi:10.1172/JCI118139
van den Elzen P, Garg S, Leon L, Brigl M, Leadbetter EA, Gumperz JE, Dascher CC, Cheng TY, Sacks FM, Illarionov PA, Besra GS, Kent SC, Moody DB, Brenner MB (2005) Apolipoprotein-mediated pathways of lipid antigen presentation. Nature 437(7060):906–910
Errera FI, Silva ME, Yeh E, Maranduba CM, Folco B, Takahashi W, Pereira AC, Krieger JE, Passos-Bueno MR (2006) Effect of polymorphisms of the MTHFR and apoE genes on susceptibility to diabetes and severity of diabetic retinopathy in Brazilian patients. Braz J Med Biol Res 39(7):883–888. doi:10.1590/S0100-879X2006000700005
Ewbank DC (2004) The APOE Gene and Differences in Life Expectancy in Europe. J Gerontol A Biol Sci Med Sci 59(1):16–20
Ferretti G, Alleva R, Taus M, Simonetti O, Cinti B, Offidani AM, Bossi G, Curatola G (1994) Abnormalities of plasma lipoprotein composition and fluidity in psoriasis. Acta Derm Venereol 74(3):171–175
Forte GI, Piccione M, Scola L, Criveflo A, Galfano C, Corsi MM, Chiapelli M, Candore G, Giuffre M, Verna R, Licastro F, Corsello G, Caruso C, Lio D (2007) Apo E genotypic frequencies among Down Syndrome Patients imply early unsuccessful aging for Apo E4 carriers. Rejuvenation Res 10(3):293–299. doi:10.1089/rej.2006.0525
Furumoto H, Nakamura K, Imamura T, Hamamoto Y, Shimizu T, Muto M, Asagami Ch (1997) Association of apo allele e2 with psoriasis vulgaris in Japanese population. Arch Dermatol Res 289:497–500. doi:10.1007/s004030050229
Gerdes LU, Klausen IC, Sihm I, Faergeman O (1992) Apolipoprotein epolymorphism in a Danish population compared to Findings in 45 other study populations around the world. Genet Epidemiol 9(3):155–167. doi:10.1002/gepi.1370090302
Hamamoto Y, Nagai K, Muto M, Furumoto H, Mogami S, Asagami C (1996) Establishment and characterization of a novel human promonocytic line from peripheral blood of a patient with psoriasis. Arch Dermatol Res 288:225–229. doi:10.1007/BF02530089
Henseler T, Christophers E (1995) Disease concomitance in psoriasis. J Am Acad Dermatol 32:982–986. doi:10.1016/0190-9622(95)91336-X
Hixson JE, Vernier DT (1990) Restriction isotyping of human apoE by gene amplification and cleavage with HhaI. J Lipid Res 31:545–548
Jasinska-Myga B, Opala G, Goetz CG, Tustanowski J, Ochadlo S, Gorzkowska A, Tyrpa J (2007) Apo E gene polymorphism and plasma cholesterol level and Parkinson disease dementia. Arch Neurol 64(2):261–265. doi:10.1001/archneur.64.2.261
Kelly ME, Clay MA, Mistry MJ, Hsieh-Li HM, Harmony JAK (1994) Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity. Cell Immunol 159:124–139. doi:10.1006/cimm.1994.1302
Koga T, Duan H, Urabe K, Furue M (2002) In situ localization of CD83-positive dendritic cells in psoriatic lesions. Dermatology 204:100–103. doi:10.1159/000051825
Lowes MA, Bowcock AM, Krueger JG (2007) Pathogenesis and therapy of psoriasis. Nature 445:866–873. doi:10.1038/nature05663
Mallbris L, Granath F, Hamsten A, Stahle M (2006) Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 54:614–621. doi:10.1016/j.jaad.2005.11.1079
Mauri M, Sinforiani E, Bono G, Cittadella R, Quattrone A, Boller F, Nappi G (2006) Interaction between apoE4 and traumatic brain injury in patients with Alzheimer’s disease and Mild Cognitive Impairment. Funct Neurol 21(4):223–228
Mehta SG, Watts GD, Adamson JL, Hutton M, Umberger G, Xiong S, Ramdeen S, Lovel MA, Kimonis VE, Smith CD (2007) ApoE is a potential modifier gene in an autosomal dominant form of frontotemporal dementia. Genet Med 9(1):9–13. doi:10.1097/GIM.0b013e31802d830d
Miller SA, Dykes DD, Polesky HF (1998) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
Miyauchi H (1991) Immunohistochemical study for the localization of apolipoprotein AI, B100 and E in normal and psoriatic skin. Igaku Kenkyu 61(2):79–86
Ng MC, Baum L, So WY, Lam VK, Wang Y, Poon E, Tomlinson B, Cheng S, Lindpainter K, Chan JC (2006) Association of lipoprotein lipase S447x, apoE exon 4 and apo C3-455T-C polymorphism on the susceptibility of diabetic nephropathy. Clin Genet 70(1):20–28. doi:10.1111/j.1399-0004.2006.00628.x
Niu W, Guo X, Su Y, Qiu C (2007) ApoE gene and LDL receptor gene polymorphisms in dyslipidemias associated essential hypertension. J Hum Hypertens 21(4):337–339
Oestreicher JL, Walters IB, Kikuchi T, Gilleaudeau P, Surette J, Schwertschlag U, Dorner AJ, Krueger JG, Trepicchio WL (2001) Molecular classification of psoriasis disease-associated genes through pharmacogenomic expression profiling. Pharmacogenomics J 1:272–287
Orem A, Cimsit G, Deger O, Orem C, Vanizor B (1999) The significance of autoantibodies against oxidatively modified LDL in patients with psoriasis. Clin Chim Acta 284:81–88. doi:10.1016/S0009-8981(99)00062-5
Panegyres PK, Beilby J, Bulsara M, Toufexis K, Wong C (2006) A study of potential interactive genetic factors in Huntington’s disease. Eur Neurol 55(4):189–192. doi:10.1159/000093867
Parmenter BA, Denney DR, Lynch SG, Middleton LS, Harlan LM (2007) Cognitive impairment in patients with multiple sclerosis: association with the apoE gene and promoter polymorphism. Mult Scler 13(1):25–32. doi:10.1177/1352458506070682
Parfenov MG, Nikolaeva TY, Sudomoina MA, Fedorova SA, Guekht AB, Gusev EI, Favorova OO (2007) Polymorphism of apo E and LPL genes and ischaemic stroke in individuals of Yakut ethnicity. J Neurol Sci 255(1–2):42–49
Rocha-Pereira P, Santos-Silva A, Rebelo I, Figueiredo A, Quintanilha A, Teixeira F (2001) Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease. Clin Chim Acta 303(1–2):33–39. doi:10.1016/S0009-8981(00)00358-2
Schiele F, De Bacquer D, Vincent-Viry M, Beisiegel U, Ehnholm C, Evans A, Kafatos A, Martins MC, Sans S, Sass C, Visvihis S, De Backer G (2000) Apolipoprotein E serum concentrations and polymorphism in six European countries: the ApoEuropa Project. Atherosclerosis 152:475–488. doi:10.1016/S0021-9150(99)00501-8
Seckin D, Tokgozoglu L, Akkaya S (1994) Are lipoprotein profile and lipoprotein (a) levels altered in men with psoriasis? J Am Acad Dermatol 31(3pt 1):445–449. doi:10.1016/S0190-9622(94)70208-X
Seishima M, Seishima M, Hua S, Abe A, Noma A (1995) ApoE phenotype does not contribute to the pathogenesis of psoriasis. Br J Dermatol 132(1):169–171. doi:10.1111/j.1365-2133.1995.tb08661.x
Seishima M, Seishima M, Mori S, Noma A (1994) Serum lipid and apolipoprotein levels in patient with psoriasis. Br J Dermatol 130(6):738–742. doi:10.1111/j.1365-2133.1994.tb03411.x
Sklavounou E, Economou-Petersen E, Karadima G, Panas M, Avramopoulos D, Varsou A, Vassilopoulos D, Petersen MB (1997) Apolipoprotein E polymorphism in the Greek population. Clin Genet 52(4):216–218
Tziakas DN, Chalikias GK, Antonoglou CO, Veletza S, Tentes JK, Kortsaris AX, Hatseras DI, Kaski JC (2006) ApoE genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease. J Am Coll Cardiol 48(12):2471–2481
Uyanik BS, Ari Z, Onur E, Gunduz K, Tanulku S, Durkan K (2002) Serum lipids and apolipoproteins in patients with psoriasis. Clin Chem Lab Med 40(1):65–68. doi:10.1515/CCLM.2002.013
Vallus G, Dlustrus B, Acsady G, Papp Z, Skopal J, Nagy Z, Prohaszka Z, Romics L, Karadi I, Nagy B (2007) Factor V Leiden and apoE genotypes in severe femoropopliteal atherosclerosis with restenosis. Clin Chim Acta 377(1–2):256–260. doi:10.1016/j.cca.2006.10.004
Waugh WH (2006) Apo E gene and macular degeneration. Ophthalmology 113(10):1888–1889. doi:10.1016/j.ophtha.2006.05.008
Weisgraber KH (1994) Apolipoprotein E structure–function relationships. Adv Protein Chem 45:249–302. doi:10.1016/S0065-3233(08)60642-7
Xiao T, Yang C, Xiao Y, Song F (1997) Serum apolipoprotein levels of psoriatic patients with normal serum lipid levels. Chin Med Sci J 12(4):224–228
Xu X, Bittman R, Duportail G, Heissler D, Vilcheze C, London E (2001) Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). Comparison of cholesterol to plant, fungal and disease-associated sterols and comparison of sphingomyelin, cerebrocides and ceramide. J Biol Chem 276(36):33540–33546. doi:10.1074/jbc.M104776200
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karpouzis, A., Caridha, R., Tripsianis, G. et al. Apolipoprotein E gene polymorphism in psoriasis. Arch Dermatol Res 301, 405–410 (2009). https://doi.org/10.1007/s00403-009-0968-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-009-0968-0